Related Experiment Video
Updated: Jun 23, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Cross interference with TNF-alpha-induced TAK1 activation via EGFR-mediated p38 phosphorylation of TAK1-binding
Myoung-Sook Shin1, Pattama Shinghirunnusorn, Yumiko Sugishima
1Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan.
Abstract:
Transforming growth factor-alpha-activated kinase 1 (TAK1) has been widely recognized as a kinase that regulates multiple intracellular signaling pathways evoked by cytokines and immune receptor activation. We have recently reported that tumor necrosis factor-alpha (TNF-alpha) triggers internalization of epidermal growth factor receptor (EGFR) through a TAK1-p38alpha signaling pathway, which results in a transient suppression of the EGFR. In the present study, we investigated the pathway of intracellular signaling in the opposite direction. Ligand-induced activation of EGFR caused phosphorylation of the TAK1-binding proteins TAB1 and TAB2 in a TAK1-independent manner. EGFR-mediated phosphorylation of TAB1 was completely inhibited by a chemical inhibitor and siRNA of p38alpha. The phosphorylation of TAB1 was occurred at Ser-423 and Thr-431, the residues underlying the p38-mediated feedback inhibition of TAK1. In contrast, phosphorylation of TAB2 was sustained, and largely resistant to p38 inhibition. The inducible phosphorylation of TAB1 interfered with a response of EGF-treated cells to TNF-alpha-induced TAK1 activation, which led to the reduction of NF-kappaB activation. Collectively, these results demonstrated that EGFR activation interfered with TNF-alpha-induced TAK1 activation via p38-mediated phosphorylation of TAB1.
Insights
Epidermal growth factor receptor (EGFR) activation interferes with tumor necrosis factor-alpha (TNF-alpha)-induced transforming growth factor-alpha-activated kinase 1 (TAK1) activation. This occurs through p38-mediated phosphorylation of TAB1, reducing NF-kappaB activation.
Area of Science:
- Cellular signaling pathways
- Kinase regulation
- Immune receptor activation
Background:
- Transforming growth factor-alpha-activated kinase 1 (TAK1) regulates cytokine and immune receptor signaling.
- Previous work showed TNF-alpha triggers EGFR internalization via TAK1-p38alpha, suppressing EGFR.
- This study explores signaling in the reverse direction: EGFR activation impacting TAK1.
Purpose of the Study:
- To investigate the intracellular signaling pathway from EGFR activation to TAK1.
- To elucidate the mechanism by which EGFR activation affects TNF-alpha-induced TAK1 activation.
Main Methods:
- Investigated ligand-induced EGFR activation.
- Utilized chemical inhibitors and siRNA for p38alpha.
- Analyzed phosphorylation of TAK1-binding proteins TAB1 and TAB2.
- Assessed NF-kappaB activation in response to EGF and TNF-alpha.
Main Results:
- EGFR activation induced TAK1-independent phosphorylation of TAB1 and TAB2.
- EGFR-mediated TAB1 phosphorylation at Ser-423 and Thr-431 was p38alpha-dependent.
- TAB1 phosphorylation interfered with TNF-alpha-induced TAK1 activation and reduced NF-kappaB activation.
- TAB2 phosphorylation was sustained and largely p38alpha-independent.
Conclusions:
- EGFR activation negatively regulates TNF-alpha-induced TAK1 activation.
- This regulation occurs via p38alpha-mediated phosphorylation of TAB1.
- The findings reveal a feedback mechanism where EGFR signaling impacts inflammatory pathways mediated by TAK1.
Related Concept Videos
TGF - β Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
